Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AEM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Applied and Environmental Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AEM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Food Microbiology

Development of a Novel Screening Method for the Isolation of “Cronobacter” spp. (Enterobacter sakazakii)

Carol Iversen, Patrick Druggan, Sandra Schumacher, Angelika Lehner, Claudia Feer, Karl Gschwend, Han Joosten, Roger Stephan
Carol Iversen
1Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland
2Quality and Safety Department, Nestlé Research Centre, Vers-chez-les-Blanc, CH-1000 Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Druggan
3Oxoid Ltd., Thermo Fisher Scientific, Basingstoke, Hampshire RG24 8PW, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Schumacher
1Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelika Lehner
1Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Feer
4QA and Food Safety Department, Hochdorf Nutritec AG, CH-6280 Hochdorf, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Gschwend
4QA and Food Safety Department, Hochdorf Nutritec AG, CH-6280 Hochdorf, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Han Joosten
2Quality and Safety Department, Nestlé Research Centre, Vers-chez-les-Blanc, CH-1000 Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Stephan
1Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: stephanr@fsafety.uzh.ch
DOI: 10.1128/AEM.02801-07
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

A differential medium, “Cronobacter” screening broth, has been designed to complement agars based on hydrolysis of chromogenic α-glucopyranoside substrates. The broth was evaluated using 329 Enterobacteriaceae strains (229 target isolates), spiked/naturally contaminated samples, and a parallel comparison with current methods for raw materials, line/end products, and factory environment samples.

Enterobacter sakazakii is an opportunistic neonatal pathogen that has been reported as an occasional contaminant of powdered infant formula (PIF) (2, 3). Recent polyphasic analysis led to the proposal of a reclassification of E. sakazakii as several novel genomospecies within a novel genus, “Cronobacter,” with the novel genus being synonymous with E. sakazakii (11, 13). Various chromogenic and fluorogenic agar media have been described for detection of Cronobacter (7, 17, 19, 20). These are based mainly on the enzyme α-glucosidase, which is constitutively expressed in Cronobacter but in few other Enterobacteriaceae (18, 21, 22). Assessment of several of these media has shown that they provide comparable sensitivities and specificities (5, 12, 16). However, it has been established that some isolates of Cronobacter do not grow well in currently proposed enrichment broths, such as modified lauryl sulfate tryptose broth (mLST) and Enterobacteriaceae enrichment broth (6, 9, 16). Samples containing only such strains could give false-negative results; therefore, the enrichment procedure should be improved. Fermentation of sucrose and metabolism of 5-bromo-4-chloro-3-indolyl-α-d-glucopyranoside have been shown to be useful distinguishing tests for Cronobacter spp. (12, 18). Therefore, a differential broth has been developed that enables samples to be screened for potential Cronobacter contamination without incorporating selective agents that may affect the recovery of sensitive strains (9).

CSB.

Cronobacter screening broth (CSB) comprises 10.0 g liter−1 peptone, 3.0 g liter−1 meat extract, 5.0 g liter−1 NaCl (7647-14-5), 0.04 g liter−1 bromocresol purple (115-40-2), 10 g liter−1 sucrose (57-50-1), and 10 mg liter−1 vancomycin hydrochloride (1404-93-9). (All chemicals are described by their Chemical Abstract Service numbers to allow an exact identification of materials independent of supplier.) The final pH value is 7.4 ± 0.1, and the optimum incubation temperature is 42°C.

Microbiological strains.

Inclusivity and exclusivity of CSB were assessed using 329 strains, including 229 target Cronobacter isolates, covering a diversity of global distribution, species, and biogroups (11, 13). The 100 nontarget Enterobacteriaceae strains included 27 species from nine genera. After 24 h at 42°C, all 229 Cronobacter strains tested were able to grow in CSB and ferment the sucrose, thus lowering the pH and effecting a change in the color of the broth from purple to yellow. The minimum inoculum required to observe a color change in CSB within 24 h was 102 CFU ml−1, as determined with the slowest-growing strain (E770). This corresponds to a final concentration of 104 CFU ml−1 after preenrichment of the sample in buffered peptone water (BPW) (CM0509; Oxoid AG, Pratteln, Switzerland). The level of competitive flora in PIF is generally low (8), the lag time for desiccated cells to recover after rehydration of PIF at 37°C has been estimated as 0.254 h (15), and the approximate doubling time at 37°C in infant formula for Cronobacter spp. is 20 min (10). Therefore, theoretically an initial contamination of only 1 CFU in a 300-g sample should be able to multiply to exceed a final concentration of 104 CFU ml−1 well within an 18-h incubation time. The sensitivity and negative predictive value (NPV) of CSB were 100% when CSB was used in conjunction with a nonselective chromogenic medium (X-TSA) comprised of tryptone soya agar (TSA) (CM0131; Oxoid AG, Pratteln, Switzerland) containing 0.15 g liter−1 5-bromo-4-chloro-3-indolyl-α-d-glucoside (108789-36-2). The specificity was 94%, and the positive predictive value (PPV) was 97.4%. The nontarget strains yielding presumptively positive reactions (6/100) were all isolates of the novel species Enterobacter pulveris (22), which ferment sucrose and metabolize 5-bromo-4-chloro-3-indolyl-α-d-glucopyranoside. However, they can be distinguished from Cronobacter spp. by using phenotypic tests (11, 22). Caution needs to be used with interpretation of commercial biochemical galleries, as these species are not yet incorporated in the corresponding databases and can be designated a nearest match to E. sakazakii. Based on data from our culture collection, all E. pulveris strains are negative for arginine dihydrolase, ornithine decarboxylase, and Voges-Proskauer tests, whereas Cronobacter strains are, respectively, 97%, 92%, and 99.5% positive for these tests. Additionally, all E. pulveris strains are positive for fermentation of d-arabitol and the methyl red test, whereas Cronobacter strains are 100% negative for fermentation of d-arabitol and 99.5% negative for the methyl red test.

Recovery from spiked samples.

To mimic the recovery of low numbers of cells from PIF, 100 g of PIF was diluted 1/10 with BPW. The rehydrated PIF was spiked with 20 target Cronobacter strains and 10 nontarget Enterobacteriaceae strains to achieve for each strain a final concentration of 1 to 10 CFU liter−1. The resulting spiked 1,000 ml of rehydrated formula was divided into 200 5-ml analytical samples; this gave an estimated average of 0.75 CFU 5 ml−1. The strains included representatives of the different Cronobacter species (13) as well as target strains that were previously found difficult to grow in Cronobacter isolation media (9). Nontarget organisms included the recently described species Enterobacter helveticus, E. turicensis, and E. pulveris (21, 22), which can be found in the same ecological niches as Cronobacter, such as dried food products and factory environments, and also yield presumptively positive colonies on chromogenic agar. The 200 spiked analytical samples were incubated for 24 h at 37°C. Each analytical sample was then diluted 1/100 into both CSB and mLST (4) and incubated for 24 h at 42°C and 44°C, respectively. All analytical samples were streaked onto X-TSA and the plates incubated at 37°C for 24 h to detect presumptively positive Cronobacter colonies. The presumptively positive colonies were distinguished using the methyl red and Voges-Proskauer tests. Bacteria were recovered from 147/200 spiked 5-ml analytical samples, with multiple isolates obtained from 17 samples. Fermentation of CSB occurred in 134 samples, and 105 gave presumptively positive colonies on chromogenic agar. Cronobacter was detected in a total of 91 of the spiked 5-ml samples, all of which were positive in CSB and produced presumptively positive colonies on the agar (Table 1). Of the 56 samples from which only nontarget strains were recovered, 43 were positive in CSB and 14 of these gave presumptively positive colonies on X-TSA. Fewer samples were found positive for Cronobacter when using mLST than when using CSB.

View this table:
  • View inline
  • View popup
TABLE 1.

Performance of mLST with chromogenic agar, CSB alone, and CSB with chromogenic agar for isolation of Cronobacter from spiked samples

Recovery from factory samples.

A total of 80 10-g samples (41 PIF, two dried infant cereals, 15 vitamin-mineral premixes, and 22 factory environmental samples) were preenriched for 24 h at 37°C in BPW at a 1/10 dilution. Each preenriched sample homogenate was then inoculated (100 μl) into 10 ml CSB, giving a 1/100 dilution of homogenate, and incubated at 42°C for 24 h, after which 10 μl was streaked onto X-TSA and incubated at 37°C for 24 h. The presumptively positive isolates were identified using ID 32E biochemical galleries (bioMérieux Industries, Marcy l'Etoile, France). No Cronobacter strains were detected in any of the PIF, infant food, or vitamin-mineral premixes, with only one nontarget presumptively positive (i.e., positive in CSB) out of 58 samples tested. Therefore, 98.3% (57/58) of these samples would correctly be identified as negative after 48 h and a decision to release could be made. For the environmental samples, 12/22 showed fermentation of CSB; nine of these produced presumptively positive colonies on chromogenic agar, of which eight were confirmed as Cronobacter.

Comparison with current methods.

Samples were obtained from multiple factory sites and divided into 322 finished products (PIF), 146 ingredients, and 482 environmental samples (950 test samples in total, comprising a comprehensive survey of the infant formula manufacturing process). All samples were preenriched for 24 h at 37°C in BPW. Sample size varied depending on the nature of the material, and dilution in BPW was 1/10. For some samples, such as starches, chocolate powders, and vitamin-mineral premixes, a dilution of 1/100 was also used. Where feasible, raw materials were tested as 25-g aliquots, PIF were tested as 30 10-g, 10 30-g, or 2 150-g aliquots, and environmental swabs were preenriched in 10 ml BPW. Preenriched samples were analyzed using the FDA method (1) and the ISO/TS 22964 method (4) as well as the CSB method. For the last method, 0.1 ml of the preenriched sample was transferred to 10 ml CSB and incubated at 42°C for 24 h. In practice, only samples in which fermentation of the carbohydrate occurs, resulting in a color change from purple to yellow, need to be streaked onto chromogenic agar. However, in this study all broths were streaked onto a modified version of chromogenic E. sakazakii agar, DFI (Druggan, Forsythe, and Iverson) formulation (mDFI) (Oxoid Ltd., Basingstoke, United Kingdom). This medium comprised 7.0 g liter−1 tryptone, 3.0 g liter−1 yeast extract (8013-01-2), 5.0 g liter−1 NaCl (7647-14-5), 0.15 g liter−1 5-bromo-4-chloro-3-indolyl-α-d-glucopyranoside (108789-36-2), 0.25 g liter−1 sodium desoxycholate (302-95-4), 1.0 g liter−1 sodium thiosulfate (7772-98-7), 1.0 g liter−1 ammonium iron(III) citrate (1185-57-5), and 13.0 g liter−1 agar-agar (9002-18-0).

Although the FDA and ISO/TS 22964 methods cite the use of yellow pigmentation and biochemical tests as indicative of positive Cronobacter isolates (1, 4), these criteria have been shown to be unreliable (5, 9, 12). Therefore, in this study presumptive Cronobacter isolates obtained using the three methods were confirmed as positive by use of a Cronobacter-specific α-glucosidase PCR assay (12). Biochemical tests and 16S rRNA gene sequencing (Fasteris S.A., Plan-les-Ouates, Switzerland) were used to indicate Cronobacter species identity (11, 13).

All three methods recovered Cronobacter from 2.17% (7/322) of end product samples. The CSB and ISO/TS 22964 methods both recovered target strains from 10.96% (16/146) of raw materials; however, the FDA method detected Cronobacter in only 3.42% (5/146) of raw materials. As these ingredients and products were from infant food production facilities, the sensitivity of the methods for detecting Cronobacter in these samples is of particular importance; both the ISO/TS 22964 and CSB methods were found to have 100% sensitivity and 100% NPV (Table 2). The advantage of using the CSB screening method is that a release decision can be made on negative samples within 48 h; also, the costs of materials and labor are considerably reduced, as only positive broths need to be streaked onto the chromogenic agars.

View this table:
  • View inline
  • View popup
TABLE 2.

Recovery of Cronobacter spp. from product, raw materials, and environment by use of CSB in combination with mDFI agar and comparison with the FDA and ISO/TS 22964 methodsa

The testing of environmental samples in production facilities is performed to verify the effectiveness of hygiene control measures aimed at minimizing product recontamination. Due to the higher level of bacterial flora in these samples, the specificity of a detection method becomes of increased importance. In this study, Cronobacter was recovered from a total of 10.37% (50/482) of the environmental samples by one or more methods. The CSB method recovered Cronobacter from 9.75% (47/482), the ISO/TS 22964 from 9.54% (46/482), and the FDA method from only 2.7% (13/482) of environmental samples. The strains that were recovered using the CSB method but not the ISO/TS 22964 method and vice versa were tested for the ability to grow in the respective media. All seven of these strains grew to >109 CFU ml−1 in CSB after 24 h at 42°C and fermented the sucrose, yielding a distinct yellow coloration. Also, all of these strains were able to grow when incubated for 24 h on mDFI and Enterobacter sakazakii identification agar at 42°C and 44°C, respectively, producing distinct blue-green colonies. However, only three of these strains were able to grow to >109 CFU ml−1 in mLST when incubated for 24 h at 44°C. The other four strains did not produce turbid cultures, and plate counts on TSA incubated for 24 h at 37°C showed that the final concentrations reached in the mLST ranged from 2.2 × 107 to 7.3 × 107 CFU ml−1, an increase of approximately 2 log from the inoculum. Therefore, the inability of the methods to recover strains from some samples is probably due to a combination of competition from other bacterial species in the samples and reduced growth rate in mLST. McNemar's test for marginal homogeneity with continuity correction showed there was no significant difference in performance of the CSB and ISO/TS 22964 methods (two-tailed P value of 1.0 and odds ratio of 0.750, with a 95% confidence interval extending from 0.11 to 4.43). For the environmental samples, both methods showed a high specificity and high NPVs and PPVs (Table 2). The sensitivity of the CSB method (94%) was slightly higher than that of the ISO/TS 22964 method (92%), demonstrating that despite the differential rather than selective nature of CSB, this method is equally suited for testing environmental samples, ingredients, and end products. Moreover, examples of all proposed Cronobacter species were isolated during this study, indicating that this method is suitable for detection of all members of this genus.

Conclusions.

A differential screening medium, CSB, has been developed to identify samples potentially contaminated with Cronobacter spp. The broth is designed to circumvent the problems encountered with selective enrichment media for these organisms and to be complementary to currently available chromogenic media in order to improve overall sensitivity and selectivity of Cronobacter detection. The CSB screening method was able to detect Cronobacter in spiked and in naturally contaminated samples. Potentially, this screening method can enable the decision to release uncontaminated product after 48 h. As CSB is a differential rather than selective enrichment broth, all Cronobacter strains are able to grow in CSB. This differential screening broth is complementary to any agar medium that incorporates a test for metabolism of α-glucopyranoside. However, while CSB has been shown to be 100% sensitive for Cronobacter species, the overall effectiveness of the method is dependent on the sensitivity and specificity of the chromogenic agar used. The numbers of positive samples found from ingredients and the environment are in line with previous findings that Cronobacter spp. are ubiquitous environmental organisms that can be isolated from various food products as well as from households (8, 14).

ACKNOWLEDGMENTS

We acknowledge James Beaves for his work on development of the mDFI media and Jean-Louis Cordier for critical reading of the manuscript. Strains used in this study were either isolated by the authors or obtained from the following collections: Nestlé Research Center, Lausanne, Switzerland; Institute for Food Safety and Hygiene, University of Zurich, Switzerland; Centre for Food Safety and Zoonoses, University College Dublin, Ireland; Health Products and Food Branch, Health Canada; Department of Medical Microbiology, Radboud University, The Netherlands; CDC, Atlanta, GA; Oxoid Ltd., Thermo Fisher Scientific, Basingstoke, United Kingdom; Food Safety Lab, Cornell University, NY; U.S. FDA CFSAN, MD; R&F Laboratories, Downers Grove, IL; bioMérieux, La Balme Les Grottes, France; Institute for Medical Microbiology and Immunology, University of Bonn, Germany; NCTC, London, United Kingdom; and ATCC, Manassas, VA.

FOOTNOTES

    • Received 12 December 2007.
    • Accepted 22 February 2008.
  • Copyright © 2008 American Society for Microbiology

REFERENCES

  1. 1.↵
    Anonymous. 2002. Isolation and enumeration of Enterobacter sakazakii from dehydrated powdered infant formula. U.S. Food and Drug Administration, Rockville, MD. http://www.cfsan.fda.gov/∼comm/mmesakaz.html .
  2. 2.↵
    Anonymous. 2004. Enterobacter sakazakii and other microorganisms in powdered infant formula: meeting report, MRA Series 6. FAO/WHO, Geneva, Switzerland.
  3. 3.↵
    Anonymous. 2006. Enterobacter sakazakii and Salmonella in powdered infant formula. Second Risk Assessment Workshop, 16 to 20 January 2006. FAO/WHO, Rome, Italy.
  4. 4.↵
    Anonymous. 2006. Milk and milk products—detection of Enterobacter sakazakii. Technical specification ISO/TS 22964. ISO/TS 22964:2006(E) and IDF/RM 210:2006(E), 1st ed. International Organization for Standardization, Geneva, Switzerland.
  5. 5.↵
    Gnanou Besse, N., A. Leclercq, V. Maladen, C. Tyburski, and B. Lombard. 2006. Evaluation of the International Organization for Standardization-International Dairy Federation (ISO-IDF) draft standard method for detection of Enterobacter sakazakii in powdered infant food formulas. J. AOAC Int.89:1309-1316.
    OpenUrlPubMed
  6. 6.↵
    Guillaume-Gentil, O., V. Sonnard, M. C. Kandhai, J. D. Marugg, and H. Joosten. 2005. A simple and rapid cultural method for detection of Enterobacter sakazakii in environmental samples. J. Food Prot.68:64-69.
    OpenUrlPubMed
  7. 7.↵
    Iversen, C., P. Druggan, and S. J. Forsythe. 2004. A selective differential medium for Enterobacter sakazakii. Int. J. Food Microbiol.96:133-139.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Iversen, C., and S. Forsythe. 2004. Isolation of Enterobacter sakazakii and other Enterobacteriaceae from powdered infant formula milk and related products. Food Microbiol.21:771-777.
    OpenUrlCrossRefWeb of Science
  9. 9.↵
    Iversen, C., and S. Forsythe. 2007. Comparison of media for the isolation of Enterobacter sakazakii. Appl. Environ. Microbiol.73:48-52.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Iversen, C., M. Lane, and S. Forsythe. 2004. The growth profile, thermotolerance and biofilm formation of Enterobacter sakazakii grown in infant formula milk. Lett. Appl. Microbiol.38:378-382.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    Iversen, C., A. Lehner, N. Mullane, E. Bidlas, I. Cleenwerck, J. Marugg, S. Fanning, R. Stephan, and H. Joosten. 2007. The taxonomy of Enterobacter sakazakii: proposal of a new genus Cronobacter gen. nov. and descriptions of Cronobacter sakazakii comb. nov. Cronobacter sakazakii subsp. sakazakii, comb. nov., Cronobacter sakazakii subsp. malonaticus subsp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov. and Cronobacter genomospecies 1. BMC Evol. Biol.7:64.
    OpenUrlCrossRefPubMed
  12. 12.↵
    Iversen, C., A. Lehner, N. Mullane, J. Marugg, S. Fanning, R. Stephan, and H. Joosten. 2007. The identification of Cronobacter spp. (Enterobacter sakazakii). J. Clin. Microbiol.45:3814-3816.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Iversen, C., N. Mullane, B. McCardell, B. D. Tall, A. Lehner, S. Fanning, R. Stephan, and H. Joosten. Cronobacter gen. nov., a new genus to accommodate the biogroups of Enterobacter sakazakii, and proposal of Cronobacter sakazakii gen. nov. comb. nov., C. malonaticus sp. nov., C. turicensis sp. nov., C. muytjensii sp. nov., C. dublinensis sp. nov., Cronobacter genomospecies 1, and of three subspecies, C. dublinensis sp. nov. subsp. dublinensis subsp. nov., C. dublinensis sp. nov. subsp. lausannensis subsp. nov., and C. dublinensis sp. nov. subsp. lactaridi subsp. nov. Int. J. Syst. Evol. Microbiol., in press.
  14. 14.↵
    Kandhai, M., M. Reij, L. Gorris, O. Guillaume-Gentil, and M. van Schothorst. 2004. Occurrence of Enterobacter sakazakii in food production environments and households. Lancet363:39-40.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    Kandhai, M., M. Reij, C. Grognou, M. van Schothorst, L. Gorris, and M. H. Zwietering. 2006. Effects of preculturing conditions on lag time and specific growth rate of Enterobacter sakazakii in reconstituted powdered infant formula. Appl. Environ. Microbiol.72:2721-2729.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    Lehner, A., S. Nitzsche, P. Breeuwer, B. Diep, K. Thelen, and R. Stephan. 2006. Comparison of two chromogenic media and evaluation of two molecular based identification systems for Enterobacter sakazakii detection. BMC Microbiol.6:15.
    OpenUrlCrossRefPubMed
  17. 17.↵
    Leuschner, R. G. K., and J. Bew. 2004. A medium for the presumptive detection of Enterobacter sakazakii in infant formula: interlaboratory study. J. AOAC Int.87:604-613.
    OpenUrlPubMed
  18. 18.↵
    Muytjens, H. L., J. van der Ros-van de Repe, and H. A. M. van Druten. 1984. Enzymatic profiles of Enterobacter sakazakii and related species with special reference to the alpha glucosidase reaction and reproducibility of the test system. J. Clin. Microbiol.20:684-686.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    Oh, S. W., and D. H. Kang. 2004. Fluorogenic selective and differential medium for isolation of Enterobacter sakazakii. Appl. Environ. Microbiol.70:5692-5694.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    Restaino, L., E. W. Frampton, W. C. Lionberg, and R. J. Becker. 2006. A chromogenic plating medium for the isolation and identification of Enterobacter sakazakii from foods, food ingredients and environmental sources. J. Food Prot.69:315-322.
    OpenUrlCrossRefPubMed
  21. 21.↵
    Stephan, R., S. Van Trappen, I. Cleenwerck, M. Vancanneyt, P. De Vos, and A. Lehner. 2007. Enterobacter turicensis sp. nov. and Enterobacter helveticus sp. nov., isolated from fruit powder. Int. J. Syst. Evol. Microbiol.57:820-826.
    OpenUrlCrossRefPubMed
  22. 22.↵
    Stephan, R., S. Van Trappen, I. Cleenwerck, C. Iversen, H. Joosten, P. De Vos, and A. Lehner. 2008. Enterobacter pulveris sp. nov., isolated from fruit powder, infant formula and an infant formula production environment. Int. J. Syst. Evol. Microbiol.58:237-241.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
Development of a Novel Screening Method for the Isolation of “Cronobacter” spp. (Enterobacter sakazakii)
Carol Iversen, Patrick Druggan, Sandra Schumacher, Angelika Lehner, Claudia Feer, Karl Gschwend, Han Joosten, Roger Stephan
Applied and Environmental Microbiology Apr 2008, 74 (8) 2550-2553; DOI: 10.1128/AEM.02801-07

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Applied and Environmental Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Development of a Novel Screening Method for the Isolation of “Cronobacter” spp. (Enterobacter sakazakii)
(Your Name) has forwarded a page to you from Applied and Environmental Microbiology
(Your Name) thought you would be interested in this article in Applied and Environmental Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Development of a Novel Screening Method for the Isolation of “Cronobacter” spp. (Enterobacter sakazakii)
Carol Iversen, Patrick Druggan, Sandra Schumacher, Angelika Lehner, Claudia Feer, Karl Gschwend, Han Joosten, Roger Stephan
Applied and Environmental Microbiology Apr 2008, 74 (8) 2550-2553; DOI: 10.1128/AEM.02801-07
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • CSB.
    • Microbiological strains.
    • Recovery from spiked samples.
    • Recovery from factory samples.
    • Comparison with current methods.
    • Conclusions.
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bacteriological Techniques
Chromogenic Compounds
Cronobacter sakazakii
food microbiology

Related Articles

Cited By...

About

  • About AEM
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AppEnvMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

 

Print ISSN: 0099-2240; Online ISSN: 1098-5336